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Results of in vivo dosimetry carried out
on the Alcyon Co-50 radiotherapeutical beam
using the SCANDITRONIX DPD-3 system with
EDE-5-type semiconductor defectors, will be
presented.
Differences Between planned and
measured entrance dose for open fields and for
fields formed using wedge compensation filters
were studied over a period of 15 months, for
patients positioned to receive their first fraction.
Of the different sites studied, most were
head&neck and breast localizations.
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The ICRU published several
Reports about volumes and doses specifications
for radiotherapy, such as the Report 29 (1978),
devoted to photon and electron beam therapy.
This report 29 becoming absolete, a new Report
was published in 1993 for external photon beam
radiotherapy, the Report 50, recommending new
definitions and more accurate specifications.
With electron beams specific problems are
raised, and the ICRU considered suitable to
prepare . a special Report for them, to be
published in the near future.
The main features of the present draft are as
follows:
1. Volumes specifications in agreement with
the ICRU Report 50,
• Volumes to be determined before treatment
planning: gross tumour volume (GTV),
clinical target volume (CTV), organs at risk
volumes (OR).
• Volume to be determined during treatment
planning: Planning target volume (PTV).
• Volumes resulting from the treatment plan
chosen: treatment volume (TV), irradiated
volume (IV).
In the future Report on electron beams, an
additional volume is defined, the internal
target volume (lTV) geometrical concept
representing the volume en-compassing the
clinical target volume, taking into consideration
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margins due to the variations of the clinical
target volume in position, shape an size.
A similar concept has been extended to organs
at risk, the planning organ at risk volume.
2. Dose specification
The general statements for photon beams
apply:
• dose at a reference point (ICRU point)
situated at or near the center of the planning
target volume and, when possible, near or on
the central axis of the electron beam at the
depth of the peak dose.
• Minimal and maximal doses in the planning
target volume
• Dose delivered to the organs at risk
• Additional information is recommended,
when possible (e.g. DVH).
With electron beams, the dose homogeneity
expected within the PTV (± 5 to ± 10 %) requires
an adaptation of the terapeutic range concept,
such that the value of the isodose surface
encompassing the PTV be situated between 85
% and 95 % of the reference dose. The peak
absorbed dose on the beam axis should always
been specified, even if it is different from the
reference dose.
At last, as in Report 50, three levels of dose
evaluation for reporting are considered,
depending on the aim of the treatment and
the data available.
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